Streamline your sales lifecycle management for Research and Development with airSlate SignNow

Increase productivity and efficiency with airSlate SignNow's tailored solution for sales lifecycle management for Research and Development. Unlock great ROI and 24/7 support.

airSlate SignNow regularly wins awards for ease of use and setup

See airSlate SignNow eSignatures in action

Create secure and intuitive e-signature workflows on any device, track the status of documents right in your account, build online fillable forms – all within a single solution.

Collect signatures
24x
faster
Reduce costs by
$30
per document
Save up to
40h
per employee / month

Our user reviews speak for themselves

illustrations persone
Kodi-Marie Evans
Director of NetSuite Operations at Xerox
airSlate SignNow provides us with the flexibility needed to get the right signatures on the right documents, in the right formats, based on our integration with NetSuite.
illustrations reviews slider
illustrations persone
Samantha Jo
Enterprise Client Partner at Yelp
airSlate SignNow has made life easier for me. It has been huge to have the ability to sign contracts on-the-go! It is now less stressful to get things done efficiently and promptly.
illustrations reviews slider
illustrations persone
Megan Bond
Digital marketing management at Electrolux
This software has added to our business value. I have got rid of the repetitive tasks. I am capable of creating the mobile native web forms. Now I can easily make payment contracts through a fair channel and their management is very easy.
illustrations reviews slider
Walmart
ExxonMobil
Apple
Comcast
Facebook
FedEx
be ready to get more

Why choose airSlate SignNow

  • Free 7-day trial. Choose the plan you need and try it risk-free.
  • Honest pricing for full-featured plans. airSlate SignNow offers subscription plans with no overages or hidden fees at renewal.
  • Enterprise-grade security. airSlate SignNow helps you comply with global security standards.
illustrations signature

Sales Lifecycle Management for Research and Development

Are you looking for a reliable solution to streamline your sales lifecycle management for Research and Development? Look no further than airSlate SignNow by airSlate - a powerful tool that enables businesses to send and eSign documents with ease. With airSlate SignNow, you can simplify your document signing process and boost productivity.

sales lifecycle management for Research and Development

airSlate SignNow offers a user-friendly interface, cost-effective solutions, and secure eSignature capabilities to make your document management process seamless. Don't let paperwork slow you down - experience the benefits of airSlate SignNow for your sales lifecycle management needs today.

Get started with airSlate SignNow and revolutionize your document signing experience!

airSlate SignNow features that users love

Speed up your paper-based processes with an easy-to-use eSignature solution.

Edit PDFs
online
Generate templates of your most used documents for signing and completion.
Create a signing link
Share a document via a link without the need to add recipient emails.
Assign roles to signers
Organize complex signing workflows by adding multiple signers and assigning roles.
Create a document template
Create teams to collaborate on documents and templates in real time.
Add Signature fields
Get accurate signatures exactly where you need them using signature fields.
Archive documents in bulk
Save time by archiving multiple documents at once.
be ready to get more

Get legally-binding signatures now!

FAQs online signature

Here is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Need help? Contact support

Trusted e-signature solution — what our customers are saying

Explore how the airSlate SignNow e-signature platform helps businesses succeed. Hear from real users and what they like most about electronic signing.

This service is really great! It has helped...
5
anonymous

This service is really great! It has helped us enormously by ensuring we are fully covered in our agreements. We are on a 100% for collecting on our jobs, from a previous 60-70%. I recommend this to everyone.

Read full review
I've been using airSlate SignNow for years (since it...
5
Susan S

I've been using airSlate SignNow for years (since it was CudaSign). I started using airSlate SignNow for real estate as it was easier for my clients to use. I now use it in my business for employement and onboarding docs.

Read full review
Everything has been great, really easy to incorporate...
5
Liam R

Everything has been great, really easy to incorporate into my business. And the clients who have used your software so far have said it is very easy to complete the necessary signatures.

Read full review
video background

How to create outlook signature

How much should a company spend on R&D? What is the spending level on research and development at world class companies? How do R&D expenses vary across industries? Very valid and interesting questions, as research and development spending is often seen as an important (expense) investment in the future. Let’s take the 30 companies in the Dow Jones Industrial Average as a benchmark, and review their R&D spending levels in 2017. In order to provide meaningful comparisons, let’s first take the companies in banking, financial services and insurance out of our sample. We can also take out companies in the retail sector, as well as those in food and beverages. We now have 21 companies left. Take a good look at the logos of these companies, as we have a polling question coming up. Which of these companies has the highest R&D spending as % of revenue in 2017? Is it semiconductor company Intel, pharmaceutical company Merck, software company Microsoft, or pharmaceutical company Pfizer? When you are logged in to YouTube and are watching this video from a computer, then please click the voting card on the top right to submit your vote. Which of these companies has the highest R&D spending as % of revenue in 2017? These four companies are the top 4 in R&D spending % in the sample of the Dow Jones Industrial Average. One question that I am expecting to get from some of the viewers is: where is Apple? Well, even though Apple is in the top 3 of spenders in absolute terms in our sample ($11.6 billion is a lot of money!), it is not among the top spenders in relative terms as you compare it to Apple’s revenue which is a stunning $229 billion. Which of these companies has the highest R&D spending as % of revenue in 2017? Pharmaceutical company Merck, at 25% of revenue. Semiconductor company Intel in second place with R&D spending at 21% of revenue, and a shared third place for Microsoft and Pfizer, both with R&D spending at 15% of revenue. Here is the data for the 15 companies out of the Dow Jones 30 that have R&D spending of more than 1% of revenue: 3M 6%, Apple 5%, Boeing 3%, Caterpillar 4%, Cisco 13%, DowDuPont 3%, GE 4%, IBM 7%, Intel 21%, Johnson&Johnson 14%, Merck 25%, Microsoft 15%, Pfizer 15%, Procter&Gamble 3%, United Technologies 4%. Clearly, pharmaceutical and computer/software related companies are at the higher end of the range. How important is the metric of R&D expense as percentage of revenue? What are its limitations? First of all, there is not a linear relationship between R&D spending and benefits, results depend on how much you spend, what you spend it on, and a mix between skill and luck. Companies could also grow through acquisition, buy a company that has progressed to a certain stage of development on its own, which for the acquiring company is mostly a balance sheet transaction involving intangible assets and goodwill. Different industries have different product development cycles: R&D spending today could lead to incremental revenue and margin next year, or five years from now, or ten years from now, or twenty years from now, if at all! Absolute $ versus relative % spend: as we saw with Apple, they spend a significant amount of money on R&D ($11.6 billion), but due to their high revenue, the percentage works out to be relatively small. Companies in the embryonic or growth stage of their development may have the opposite: a very high R&D expense % due to relatively low revenue (in the denominator). Innovation and business improvement in general can occur outside R&D. Lastly, there is R&D OpEx (expenses), and there is R&D CapEx (capital investments). R&D expense as percentage of revenue does not capture both. Hopefully this puts the discussion in perspective. R&D as percentage of revenue is an interesting metric, but like so many other metrics, it only tells part of the story! Thank you for watching! If you enjoyed this R&D benchmarking discussion, then please give it a thumbs up! On this end screen, there are a few suggestions of videos you can watch next. Please subscribe to the Finance Storyteller YouTube channel! Thank you.

Show more
be ready to get more

Get legally-binding signatures now!

Sign up with Google